In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.
The last five months have seen a wave of proposals and policies from CMS related to everything from updates to coverage of pain procedures to fraud crackdowns and claims documentation requirements.
The GLP‑1 Bridge pilot program would allow Medicare to broadly cover weight‑loss versions of GLP‑1 medications, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results